Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study.

Koppe U, Marcus U, Albrecht S, Jansen K, Jessen H, Gunsenheimer-Bartmeyer B, Bremer V.

J Int AIDS Soc. 2019 Oct;22(10):e25395. doi: 10.1002/jia2.25395.

2.

Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in Germany.

Hanke K, Faria NR, Kühnert D, Yousef KP, Hauser A, Meixenberger K, Hofmann A, Bremer V, Bartmeyer B, Pybus O, Kücherer C, von Kleist M, Bannert N.

J Virol. 2019 May 29;93(12). pii: e02238-18. doi: 10.1128/JVI.02238-18. Print 2019 Jun 15.

PMID:
30944175
3.

Bacterial sexually transmitted infections.

Buder S, Schöfer H, Meyer T, Bremer V, Kohl PK, Skaletz-Rorowski A, Brockmeyer N.

J Dtsch Dermatol Ges. 2019 Mar;17(3):287-315. doi: 10.1111/ddg.13804.

PMID:
30920748
4.

Bakterielle sexuell übertragbare Infektionen.

Buder S, Schöfer H, Meyer T, Bremer V, Kohl PK, Skaletz-Rorowski A, Brockmeyer N.

J Dtsch Dermatol Ges. 2019 Mar;17(3):287-317. doi: 10.1111/ddg.13804_g.

PMID:
30920739
5.

Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o.

Wang B, Krüger L, Machnowska P, Eshetu A, Gunsenheimer-Bartmeyer B, Bremer V, Hauser A, Bannert N, Bock CT.

Virol J. 2019 Mar 4;16(1):28. doi: 10.1186/s12985-019-1135-7.

6.

Impact of health insurance status among migrants from sub-Saharan Africa on access to health care and HIV testing in Germany: a participatory cross-sectional survey.

Müllerschön J, Koschollek C, Santos-Hövener C, Kuehne A, Müller-Nordhorn J, Bremer V.

BMC Int Health Hum Rights. 2019 Mar 5;19(1):10. doi: 10.1186/s12914-019-0189-3.

7.

Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spots.

Hauser A, Heiden MA, Meixenberger K, Han O, Fiedler S, Hanke K, Koppe U, Hofmann A, Bremer V, Bartmeyer B, Kuecherer C, Bannert N.

J Virol Methods. 2019 Apr;266:114-120. doi: 10.1016/j.jviromet.2019.02.002. Epub 2019 Feb 7.

PMID:
30738741
8.

Heterogeneity Matters: Predicting Self-Esteem in Online Interventions Based on Ecological Momentary Assessment Data.

Bremer V, Funk B, Riper H.

Depress Res Treat. 2019 Jan 13;2019:3481624. doi: 10.1155/2019/3481624. eCollection 2019.

9.

History of detention and the risk of hepatitis C among people who inject drugs in Germany.

Gassowski M, Nielsen S, Bannert N, Bock CT, Bremer V, Ross RS, Wenz B, Marcus U, Zimmermann R; DRUCK Study Group.

Int J Infect Dis. 2019 Apr;81:100-106. doi: 10.1016/j.ijid.2019.01.015. Epub 2019 Jan 15.

10.

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.

Hauser A, Hofmann A, Meixenberger K, Altmann B, Hanke K, Bremer V, Bartmeyer B, Bannert N.

PLoS One. 2018 Nov 8;13(11):e0206234. doi: 10.1371/journal.pone.0206234. eCollection 2018.

11.

Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany.

Lang AS, An der Heiden M, Jansen K, Sailer A, Bremer V, Dudareva S; Chlamydia trachomatis laboratory sentinel team.

BMC Infect Dis. 2018 Aug 25;18(1):424. doi: 10.1186/s12879-018-3323-2.

12.

Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis.

Bremer V, Becker D, Kolovos S, Funk B, van Breda W, Hoogendoorn M, Riper H.

J Med Internet Res. 2018 Aug 21;20(8):e10275. doi: 10.2196/10275.

13.

Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study.

Derks L, Gassowski M, Nielsen S, An der Heiden M, Bannert N, Bock CT, Bremer V, Kücherer C, Ross S, Wenz B, Marcus U, Zimmermann R; DRUCK-study group.

Int J Drug Policy. 2018 Sep;59:54-62. doi: 10.1016/j.drugpo.2018.06.011. Epub 2018 Jul 11.

PMID:
30005420
14.

Predicting therapy success for treatment as usual and blended treatment in the domain of depression.

van Breda W, Bremer V, Becker D, Hoogendoorn M, Funk B, Ruwaard J, Riper H.

Internet Interv. 2018 Jun;12:100-104. doi: 10.1016/j.invent.2017.08.003.

15.

Robust and sensitive subtype-generic HIV-1 pol genotyping for use with dried serum spots in epidemiological studies.

Hauser A, Meixenberger K, Machnowska P, Fiedler S, Hanke K, Hofmann A, Bartmeyer B, Bremer V, Bannert N, Kuecherer C.

J Virol Methods. 2018 Sep;259:32-38. doi: 10.1016/j.jviromet.2018.05.013. Epub 2018 May 31.

PMID:
29859195
16.

Impact of HIV knowledge and stigma on the uptake of HIV testing - Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany.

Kuehne A, Koschollek C, Santos-Hövener C, Thorlie A, Müllerschön J, Mputu Tshibadi C, Mayamba P, Batemona-Abeke H, Amoah S, Wangare Greiner V, Dela Bursi T, Bremer V.

PLoS One. 2018 Apr 11;13(4):e0194244. doi: 10.1371/journal.pone.0194244. eCollection 2018.

17.

Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.

Buder S, Dudareva S, Jansen K, Loenenbach A, Nikisins S, Sailer A, Guhl E, Kohl PK, Bremer V; GORENET study group.

BMC Infect Dis. 2018 Jan 17;18(1):44. doi: 10.1186/s12879-018-2944-9.

18.

A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.

Haussig JM, Nielsen S, Gassowski M, Bremer V, Marcus U, Wenz B, Bannert N, Bock CT, Zimmermann R; DRUCK study group.

Int J Infect Dis. 2018 Jan;66:5-13. doi: 10.1016/j.ijid.2017.10.008. Epub 2017 Oct 31.

19.

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany.

Müller J, Schmidt D, Kollan C, Lehmann M, Bremer V, Zimmermann R.

BMC Public Health. 2017 Oct 25;17(1):843. doi: 10.1186/s12889-017-4840-4.

20.

[Sexually transmitted infections in Germany : The current epidemiological situation].

Bremer V, Dudareva-Vizule S, Buder S, An der Heiden M, Jansen K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Sep;60(9):948-957. doi: 10.1007/s00103-017-2590-1. German.

PMID:
28741188
21.

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014.

Hofmann A, Hauser A, Zimmermann R, Santos-Hövener C, Bätzing-Feigenbaum J, Wildner S, Kücherer C, Bannert N, Hamouda O, Bremer V, Bartmeyer B.

BMC Infect Dis. 2017 Jul 11;17(1):484. doi: 10.1186/s12879-017-2585-4.

22.

Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control.

Korr G, Thamm M, Czogiel I, Poethko-Mueller C, Bremer V, Jansen K.

BMC Infect Dis. 2017 Jul 6;17(1):471. doi: 10.1186/s12879-017-2527-1.

23.

Generation and Characterization of Acid Tolerant Fibrobacter succinogenes S85.

Wu CW, Spike T, Klingeman DM, Rodriguez M, Bremer VR, Brown SD.

Sci Rep. 2017 May 23;7(1):2277. doi: 10.1038/s41598-017-02628-w.

24.
25.

Reply to: "Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030".

Zimmermann R, Kollan C, Ingiliz P, Mauss S, Schmidt D, Bremer V.

J Hepatol. 2017 Aug;67(2):420-422. doi: 10.1016/j.jhep.2017.03.033. Epub 2017 Apr 12. No abstract available.

PMID:
28412291
26.

Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014.

Dudareva-Vizule S, Haar K, Sailer A, Jansen K, Hamouda O, Wisplinghoff H, Tiemann C, Pape E, Bremer V; Chlamydia trachomatis laboratory sentinel team.

Euro Surveill. 2017 Feb 9;22(6). pii: 30459. doi: 10.2807/1560-7917.ES.2017.22.6.30459.

27.

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.

Zimmermann R, Kollan C, Ingiliz P, Mauss S, Schmidt D, Bremer V.

J Hepatol. 2017 Jul;67(1):15-22. doi: 10.1016/j.jhep.2017.01.024. Epub 2017 Feb 9.

PMID:
28189752
28.

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014.

Hauser A, Hofmann A, Hanke K, Bremer V, Bartmeyer B, Kuecherer C, Bannert N.

Euro Surveill. 2017 Jan 12;22(2). pii: 30436. doi: 10.2807/1560-7917.ES.2017.22.2.30436.

29.

Schnelltest-Diagnostik sexuell übertragbarer Infektionen in niedrigschwelligen Einrichtungen : Gemeinsame Stellungnahme des RKI, PEI und der DSTIG.

Meyer T, Schüttler CG, Straube E, Roß RS, Stürmer M, Jansen K, Buder S, Nick S, Hagedorn HJ, Bremer V, Brockmeyer NH.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Feb;60(2):245-254. doi: 10.1007/s00103-016-2496-3. German.

PMID:
27995270
30.

STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11.

Bremer V, Haar K, Gassowski M, Hamouda O, Nielsen S.

BMC Public Health. 2016 Nov 21;16(1):1175.

31.

Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015.

Jansen K, Schmidt AJ, Drewes J, Bremer V, Marcus U.

Euro Surveill. 2016 Oct 27;21(43). doi: 10.2807/1560-7917.ES.2016.21.43.30382.

32.
33.

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).

Wenz B, Nielsen S, Gassowski M, Santos-Hövener C, Cai W, Ross RS, Bock CT, Ratsch BA, Kücherer C, Bannert N, Bremer V, Hamouda O, Marcus U, Zimmermann R; DRUCK Study group.

BMC Public Health. 2016 Sep 5;16:927. doi: 10.1186/s12889-016-3545-4.

34.

Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany.

Nielsen S, Gassowski M, Wenz B, Bannert N, Bock CT, Kücherer C, Ross RS, Bremer V, Marcus U, Zimmermann R; DRUCK study group.

Hepatol Med Policy. 2016 Sep 1;1:8. doi: 10.1186/s41124-016-0016-6. eCollection 2016.

35.

Response to the calculation of population attributable fractions (PAFs) of risk factors for hepatitis C transmission.

Schmidt AJ, Bremer V.

AIDS. 2016 Jun 19;30(10):1683-4. doi: 10.1097/QAD.0000000000001090. No abstract available.

PMID:
27243777
36.

Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices.

Santos-Hövener C, Marcus U, Koschollek C, Oudini H, Wiebe M, Ouedraogo OI, Thorlie A, Bremer V, Hamouda O, Dierks ML, An der Heiden M, Krause G.

BMC Public Health. 2015 Aug 6;15:753. doi: 10.1186/s12889-015-2098-2.

37.

[Laboratory practices: diagnostics and antibiotics resistance testing of Neisseria gonorrhoeae in Germany].

Loenenbach A, Dudareva-Vizule S, Buder S, Sailer A, Kohl PK, Bremer V.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Aug;58(8):866-874. doi: 10.1007/s00103-015-2191-9. German.

PMID:
26112875
38.

S2k guideline* "Diagnosis and therapy of syphilis"--short version.

Schöfer H, Weberschock T, Bräuninger W, Bremer V, Dreher A, Enders M, Esser S, Hamouda O, Hagedorn HJ, Handrick W, Krause W, Mayr C, Münstermann D, Nast A, Ochsendorf F, Petry U, Potthoff A, Prange H, Rieg S, Schneede P, Sing A, Weber J, Wichelhaus TA, Brockmeyer N.

J Dtsch Dermatol Ges. 2015 May;13(5):472-80. doi: 10.1111/ddg.12574. No abstract available.

PMID:
25918100
39.

Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis.

Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A.

Cancer Epidemiol. 2014 Aug;38(4):329-38. doi: 10.1016/j.canep.2014.06.002. Epub 2014 Jun 28. Review.

PMID:
24986642
40.

[Epidemiological developments of selected sexually transmitted infections in Germany].

Hamouda O, Bremer V, Marcus U, Bartmeyer B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Dec;56(12):1600-8. doi: 10.1007/s00103-013-1866-3. German.

PMID:
24337121
41.

An assessment of the current Chlamydia trachomatis laboratory practices in Germany.

Schmidt D, Päschke H, Bremer V, Hamouda O, Reischl U, Sailer A, Haar K.

Gesundheitswesen. 2014 Oct;76(10):e44-50. doi: 10.1055/s-0033-1355406. Epub 2013 Nov 7.

PMID:
24203685
42.

Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006.

Haar K, Bremer V, Houareau C, Meyer T, Desai S, Thamm M, Hamouda O.

Euro Surveill. 2013 Aug 22;18(34). pii: 20562.

43.

Effect of sulfur content in wet or dry distillers grains fed at several inclusions on cattle growth performance, ruminal parameters, and hydrogen sulfide.

Sarturi JO, Erickson GE, Klopfenstein TJ, Vasconcelos JT, Griffin WA, Rolfe KM, Benton JR, Bremer VR.

J Anim Sci. 2013 Oct;91(10):4849-60. doi: 10.2527/jas.2012-5627. Epub 2013 Jul 26.

PMID:
23893985
44.

[Activities related to STIs and HIV and data collection in German local health authorities, 2012 : can we harvest the data?].

Altmann M, Nielsen S, Hamouda O, Bremer V.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul;56(7):922-9. doi: 10.1007/s00103-013-1763-9. German.

PMID:
23708861
45.

[Sexual health in Germany: indicators as instruments for describing, planning and evaluating : indicators of the German STI society].

Jansen K, Bremer V, von Rüden U, Steffan E, Nitschke H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul;56(7):913-21. doi: 10.1007/s00103-013-1762-x. German.

PMID:
23708860
46.

Syphilis on the rise again in Germany--results from surveillance data for 2011.

Bremer V, Marcus U, Hamouda O.

Euro Surveill. 2012 Jul 19;17(29). pii: 20222.

47.

Prevalence of Chlamydia trachomatis among young German adolescents, 2005-06.

Desai S, Meyer T, Thamm M, Hamouda O, Bremer V.

Sex Health. 2011 Mar;8(1):120-2. doi: 10.1071/SH10036.

PMID:
21371394
48.

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005.

Gilsdorf A, Hofmann A, Hamouda O, Bremer V.

BMC Infect Dis. 2010 Apr 19;10:98. doi: 10.1186/1471-2334-10-98.

49.

Emissions savings in the corn-ethanol life cycle from feeding coproducts to livestock.

Bremer VR, Liska AJ, Klopfenstein TJ, Erickson GE, Yang HS, Walters DT, Cassman KG.

J Environ Qual. 2010 Feb 19;39(2):472-82. doi: 10.2134/jeq2009.0283. Print 2010 Mar-Apr.

PMID:
20176820
50.

Differences and commonalities of national field epidemiology training programmes in Europe.

Krause G, Aavitsland P, Alpers K, Barrasa A, Bremer V, Helynck B, Perra A.

Euro Surveill. 2009 Oct 29;14(43). pii: 19378.

Supplemental Content

Loading ...
Support Center